Cargando…

Evaluating the benefits of home-based management of atrial fibrillation: current perspectives

Atrial fibrillation (AF) is the most common arrhythmia worldwide, leading to an extensive public health and economic burden. The increasing incidence and prevalence of AF is due to the advancing age of the population, structural heart disease, hypertension, diabetes, and thyroid disease. The majorit...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sheikh, Azfar B, Felzer, Jamie R, Munir, Abdullah Bin, Morin, Daniel P, Lavie, Carl J
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2016
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5085276/ https://www.ncbi.nlm.nih.gov/pubmed/27799843 http://dx.doi.org/10.2147/POR.S96670

Ejemplares similares

Protecting against sedentary lifestyle, left atrial enlargement and atrial fibrillation
por: Sanchis-Gomar, Fabian, et al.
Publicado: (2022)

Catheter ablation for the management of atrial fibrillation: current technical perspectives
por: Hong, Kathryn Lauren, et al.
Publicado: (2020)

The current approach of atrial fibrillation management
por: Amin, Anish, et al.
Publicado: (2016)

Dabigatran etexilate versus warfarin in management of non-valvular atrial fibrillation in UK context: quantitative benefit-harm and economic analyses
por: Pink, Joshua, et al.
Publicado: (2011)

Current Data and Future Perspectives on Patients with Atrial Fibrillation and Cancer
por: De Luca, Leonardo, et al.
Publicado: (2023)

Trends in the management of atrial fibrillation: A neurologist's perspective
por: Hedna, Vishnumurthy Shushrutha, et al.
Publicado: (2012)

Managing atrial fibrillation in the global community: The European perspective
por: Kaba, Riyaz A, et al.
Publicado: (2013)

Rationale and current perspective for early rhythm control therapy in atrial fibrillation
por: Van Gelder, Isabelle C., et al.
Publicado: (2011)

Percutaneous Treatment Approaches in Atrial Fibrillation: Current Landscape and Future Perspectives
por: Theofilis, Panagiotis, et al.
Publicado: (2022)

Gender-Based Clinical, Therapeutic Strategies and Prognosis Differences in Atrial Fibrillation
por: Quesada, Aurelio, et al.
Publicado: (2023)

Defining the benefit: Cardioversion of persistent atrial fibrillation
por: Nedios, Sotirios, et al.
Publicado: (2021)

Current Issues in Atrial Fibrillation
por: Khaykin, Yaariv, et al.
Publicado: (2012)

Atrial fibrillation: the current epidemic
por: Morillo, Carlos A, et al.
Publicado: (2017)

New Perspective in Atrial Fibrillation
por: Sagnard, Audrey, et al.
Publicado: (2020)

Patient perspective on the management of atrial fibrillation in five European countries
por: Bakhai, Ameet, et al.
Publicado: (2013)

Management of atrial fibrillation
por: Kakar, Puneet, et al.
Publicado: (2007)

Management of atrial fibrillation
por: Vergara, Pasquale, et al.
Publicado: (2014)

Benefits of prescribing low-dose digoxin in atrial fibrillation
por: Rosca, Ciprian Ilie, et al.
Publicado: (2021)

Regional implementation of atrial fibrillation screening: benefits and pitfalls
por: Theunissen, Luc J H J, et al.
Publicado: (2022)

The neurocognitive effects of atrial fibrillation: benefits of the ABC pathway
por: Calvert, Peter, et al.
Publicado: (2023)

Dronedarone: current evidence for its safety and efficacy in the management of atrial fibrillation
por: Schweizer, Patrick A, et al.
Publicado: (2011)

The Current Role of Omega-3 Fatty Acids in the Management of Atrial Fibrillation
por: Christou, Georgios A., et al.
Publicado: (2015)

Current management of atrial fibrillation: an observational study in NHS primary care
por: Kassianos, George, et al.
Publicado: (2013)

Management of atrial fibrillation-flutter: uptodate guideline paper on the current evidence
por: Shah, Syed Raza, et al.
Publicado: (2018)

Epidemiology of atrial fibrillation: European perspective
por: Zoni-Berisso, Massimo, et al.
Publicado: (2014)

Survey of current perspectives on consumer-available digital health devices for detecting atrial fibrillation
por: Ding, Eric Y., et al.
Publicado: (2020)

Left atrial appendage closure device outcomes among cirrhosis patients with atrial fibrillation: a United States National Cohort Study
por: Mir, Tanveer, et al.
Publicado: (2023)

Management of postoperative atrial fibrillation
por: Omae, Takeshi, et al.
Publicado: (2012)

Dronedarone in the management of atrial fibrillation
por: Saleem, TS Mohamed, et al.
Publicado: (2010)

Atrial Fibrillation: Mechanisms and Management
por: Liu, Tong, et al.
Publicado: (2019)

Atrial fibrillation: an update on management
por: McCallum, Craig J, et al.
Publicado: (2019)

Potential benefits of pharmacist intervention in the detection and therapy of atrial fibrillation
por: Adam, Lauren
Publicado: (2021)

Comparative effectiveness of dabigatran, rivaroxaban, apixaban and warfarin in the management of patients with non-valvular atrial fibrillation
por: Pink, Joshua, et al.
Publicado: (2013)

Atrial fibrillation and heart failure: A contemporary review of current management approaches
por: Lee, Justin Z., et al.
Publicado: (2021)

Current Status of Internal Cardioversion in Atrial Fibrillation
por: Plewan, Andreas, et al.
Publicado: (2002)

Current State of the Surgical Treatment of Atrial Fibrillation
por: Sandoval, Elena, et al.
Publicado: (2011)

Current Hot Potatoes in Atrial Fibrillation Ablation
por: Roten, Laurent, et al.
Publicado: (2012)

Current Understanding on Mechanisms Leading to Atrial Fibrillation
por: Cha, Myung-Jin
Publicado: (2018)

The Atrial Fibrillation Better Care pathway for managing atrial fibrillation: a review
por: Stevens, David, et al.
Publicado: (2021)

Left atrial fibrosis in atrial fibrillation: Mechanisms, clinical evaluation and management
por: Ma, Jin, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_e830jkfao12b7eos2bgtqkao1a